Progress in Treating Advanced Melanoma: Pharmacists
In the United States, about 13% of patients present with advanced melanoma (9% with regional disease and 4% with distant metastatic disease).
LeAnn B. Norris, PharmD, FCCP, BCPS, BCOP, Clinical Associate Professor, University of South Carolina College of Pharmacy, Columbia, South Carolina
At the completion of this activity, the participant will be able to:
- Identify the treatment options for patients with advanced melanoma
- Examine the latest clinical data for patients with advanced melanoma
- Explain the role of the pharmacist in supporting optimal treatment strategies in advanced melanoma management
TARGET AUDIENCE: Pharmacists
ACTIVITY TYPE: Application
RELEASE DATE: December 28, 2018
EXPIRATION DATE: January 12, 2020
ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours
FEE: This lesson is offered for free at www.pharmacytimes.org.